Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,257.28
+8.030.25%
Number of Gainers:22
Number of Losers:8
Number of Flat:1
PE:- -
High:3,288.46
Open:3,249.56
Low:3,249.56
Close:3,249.25
Volume:378.34M
Turnover:43.80B
Market Cap:6.17T
Float Cap:5.44T

Loading ...

U.s. Stocks on the Move-Pinterest, Intel, Slb

Reuters
·
Aug 31

The Stock Market Rally is About to Face Its Biggest Test

Dow Jones
·
Aug 31

Bernstein Sticks to Their Hold Rating for MARA Holdings (MARA)

TIPRANKS
·
Aug 31

Moonshot AI seeks up to 30% revenue share from major cloud providers for its Kimi models

Deep News
·
Aug 31

Does Adding Qualcomm’s Akash Palkhiwala to the Board Sharpen Applied Materials’ AI Strategy Narrative (AMAT)?

Simply Wall St.
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

AECOM Named Design Partner for Freeway Project in New Zealand

MT Newswires Live
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Model YL rear suspension failures plague owners as Tesla juggles record deliveries with slumping profits

Deep News
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Aug 31

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Aug 31

AECOM Named Design Partner for New Zealand Northland Corridor Section One Project

Reuters
·
Aug 31

Pacific Booker Engages Tetra Tech for Morrison Copper-Gold Project Pre-Feasibility Study

Reuters
·
Aug 31

AECOM Appointed as Design Partner on New Zealand’s Northland Corridor, Section One

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion

Reuters
·
Aug 31

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31